<p>J. Mel Sorensen, President and CEO of Galera Therapeutics Inc., has reported a disposal of common shares of Galera Therapeutics Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000905148-25-004171), on November 24, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

GRTX

<p>J. Mel Sorensen, CEO of Galera Therapeutics Inc., reported the sale of common shares of the company. The filing is available via EDGAR, the SEC's system. This AI-generated news is for informational purposes and not financial advice.</p>

Galera Therapeutics CEO Mel Sorensen Reports Sale of Common Shares